Liquidia (LQDA) Operating Income (2020 - 2026)
Liquidia (LQDA) posted quarterly Operating Income of $61.5 million for Q1 2026, up 273.62% year-over-year from $16.5 million in Q1 2025, and up 210.83% quarter-over-quarter from $19.8 million in Q4 2025.
Liquidia (LQDA) Operating Income (2020 - 2026) Analysis & Trends
Liquidia's Operating Income history runs 7 years deep, the most recent figure standing at $61.5 million for Q1 2026.
- In Q1 2026, Operating Income rose 273.62% year-over-year to $61.5 million; the TTM figure through Mar 2026 stood at $45.6 million (up 135.61% YoY), while the FY2025 annual figure was -$51.4 million, up 57.64% from the prior year.
- Operating Income for Q1 2026 stood at $61.5 million, up from $19.8 million in the prior quarter.
- The five-year high for Operating Income was $61.5 million in Q1 2026, with the low at -$37.5 million in Q2 2025.
- The 5-year median for Operating Income is -$14.9 million (2023), against an average of -$13.1 million.
- The sharpest annual moves came in 2023 and 2026: Operating Income plunged 306.9% in 2023, then jumped 273.62% in 2026.
- Liquidia's Operating Income stood at -$6.5 million in 2022, then slumped by 306.9% to -$26.4 million in 2023, then plunged by 36.58% to -$36.1 million in 2024, then jumped by 154.8% to $19.8 million in 2025, then soared by 210.83% to $61.5 million in 2026.
- Business Quant data shows LQDA's Operating Income at $61.5 million in Q1 2026, $19.8 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Liquidia | 6.45 Bn | 6.17 Bn | 160.92 Mn | 85.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 85.52 Mn |
| Mar 31, 2026 | 61.50 Mn |
| Dec 31, 2025 | 19.79 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | -37.51 Mn |
| Mar 31, 2025 | -35.43 Mn |
| Dec 31, 2024 | -36.11 Mn |
| Sep 30, 2024 | -29.19 Mn |
| Jun 30, 2024 | -27.20 Mn |
| Mar 31, 2024 | -28.80 Mn |
| Dec 31, 2023 | -26.44 Mn |
| Sep 30, 2023 | -14.89 Mn |
| Jun 30, 2023 | -22.83 Mn |
| Mar 31, 2023 | -9.23 Mn |
| Dec 31, 2022 | -6.50 Mn |
| Sep 30, 2022 | -8.83 Mn |
| Jun 30, 2022 | -8.97 Mn |
| Mar 31, 2022 | -14.47 Mn |
| Dec 31, 2021 | -11.36 Mn |
| Sep 30, 2021 | -7.08 Mn |